🏅 FDA Orphan Designation
Erwinase
Erwinia L-asparaginase
Manufacturer: Jazz Pharmaceuticals, Inc.
Indicated for:
FDA-Approved Indications (1)
Acute lymphoblastic leukemiaOrphan Designation
Treatment of patients with acute lymphoblastic leukemia (ALL) who have developed hypersensitivity to E. coli-derived asparaginase.
Indications & Usage
Treatment of patients with acute lymphoblastic leukemia (ALL) who have developed hypersensitivity to E. coli-derived asparaginase.
💙 Support Programs
View all →Erwinase
Jazz Pharmaceuticals, Inc.
Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.
Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.